Home>News> FDA’s Hahn: No sign China has affected U.S. drug supply during coronavirus pandemic

FDA’s Hahn: No sign China has affected U.S. drug supply during coronavirus pandemic

With pharmaceutical supply chains under immense pressure due to the novel coronavirus, China’s role as a global ingredient producer has come under scrutiny. Despite fears the East Asian nation could shut off the tap for U.S. drugs, the FDA said it hasn’t yet noticed major signs for concern.
 
The FDA hasn’t seen a shortage of active pharmaceutical ingredients (APIs) sourced from China due to the ongoing novel coronavirus outbreak but is “closely monitoring the situation,” FDA Commissioner Stephen Hahn told Fox News on Sunday.

Tags: